ReviewFrontiers in endocrinology2026
Roles of gut metabolites on bone mineralization and remodeling: impact of metabolic dysregulation on the gut-immune-bone axis.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gut microbiota, the community of microorganisms in the gastrointestinal (GI) tract, plays many critical roles in the maintenance of an individual's health by regulating bone metabolism. Bone mass has been linked to the GI system because nutrients (minerals) are absorbed to maintain bone homeostasis. Dysbiosis of gut microbiota due to metabolic deregulation associated with obesity, fatty liver, and inflammatory status of an individual promotes altered gut microbial diversity, gut-epithelial integrity, releases of harmful gut metabolites those could mediate malabsorption of nutrients such as calcium, vitamin D, omega-3 fatty acids, phosphorous, magnesium, and other key minerals essential for bone mineralization and remodeling in maintaining bone mass through the controlled processes of bone formation and resorption activities. Postbiotics and related products show promising roles in restoring intestinal barrier integrity by reducing systemic inflammation and stimulating the immune system, thereby preventing bone loss. Manipulating the host gut microbiota by sustained release of microbiota-derived metabolites at target sites can help modulate gut homeostasis by regulating redox balance, macrophage polarization, and controlling systemic inflammation. Although several reviews highlighted the roles of gut microbiota, the specific roles of gut metabolites in bone metabolism and associated disorders as a result of metabolic dysregulation remain limited. This narrative review highlights the emerging roles of gut metabolites, postbiotics and related products in regulating intestinal integrity, immune responses, and inflammation, thereby protecting against bone loss.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.